Related Experiment Video

Updated: Sep 5, 2025

P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives
10:26

P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives

Published on: June 15, 2020

11.0K

PTEN: An Emerging Potential Target for Therapeutic Intervention in Respiratory Diseases

Bangrong Cai1,2, Liu Yang1, Young Do Jung3

  • 1Collaborative Innovation Center for Chinese Medicine and Respiratory Diseases Co-Constructed by Henan Province & Education Ministry of P.R. Henan Key Laboratory of Chinese Medicine for Respiratory Disease, Henan University of Chinese Medicine, China.

Oxidative Medicine and Cellular Longevity
|July 11, 2022
PubMed

Insights

Phosphatase and tensin homolog (PTEN) is a tumor suppressor crucial for cell regulation. Decreased PTEN levels are linked to various respiratory diseases, suggesting new therapeutic targets.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Pathology

Background:

  • Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) is a critical tumor suppressor regulating cellular processes like proliferation and survival.
  • Reduced PTEN levels or activity are associated with cancer and diverse respiratory diseases.
  • Understanding PTEN's role in respiratory diseases is vital for developing targeted therapies.

Purpose of the Study:

  • To provide a comprehensive overview of PTEN's molecular and cellular mechanisms in respiratory disease initiation and progression.
  • To highlight recent research on PTEN expression and regulation in various airway pathological conditions.
  • To discuss clinical implications of PTEN alterations and potential therapeutic strategies.

Main Methods:

  • Literature review of current research on PTEN in respiratory diseases.
  • Analysis of PTEN's role in asthma, pulmonary hypertension (PAH), COPD, IPF, and acute lung injury (ALI).
  • Examination of PTEN regulation and its impact on cellular functions.

Main Results:

  • PTEN plays a significant role in the pathogenesis of asthma, PAH, COPD, IPF, and ALI.
  • Alterations in PTEN expression and function are implicated in the progression of these respiratory conditions.
  • Novel findings reveal PTEN's complex involvement in airway inflammation and injury.

Conclusions:

  • PTEN is a key regulator in respiratory disease development and progression.
  • Restoring PTEN expression and function presents a promising therapeutic avenue for respiratory diseases.
  • Further research into PTEN mechanisms can lead to effective treatments for lung conditions.

More Related Videos

Assessment of the Cytotoxic and Immunomodulatory Effects of Substances in Human Precision-cut Lung Slices12:04

Assessment of the Cytotoxic and Immunomodulatory Effects of Substances in Human Precision-cut Lung Slices

Published on: May 9, 2018

14.0K
Generation of Human 3D Lung Tissue Cultures 3D-LTCs for Disease Modeling05:47

Generation of Human 3D Lung Tissue Cultures 3D-LTCs for Disease Modeling

Published on: February 12, 2019

21.0K

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
223
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
569
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
438
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
290
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
422
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.7K